As of November 10, 2026, Replimune Group, Inc. is a publicly traded company (Nasdaq: REPL). The largest holder reporting an active stake on Schedule 13D is Baker Bros. Advisors LP, at 11.8%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include RTW Investments (8.9%), Ridgeback Capital Investments L.P. (8.7%), Montanova Capital, LLC (7.9%) (Schedule 13D/A, August 11, 2026).
Is this your company?
About to sign with, pay or invest in Replimune Group, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Replimune Group, Inc. a real, registered company?
- Replimune Group, Inc. files with the SEC under CIK 1737953 (its SEC filings).
- Its shares are listed under the ticker REPL on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Woburn, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under REPLIMUNE GROUP INC in our court records and SEC 8-K records (as of 2026-11-10).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Ridgeback Capital Investments L.P. (filed 2026-08-14).
Who are Replimune Group, Inc.'s owners and officers?
Replimune Group, Inc.: incorporated in Delaware; business address in Woburn, Massachusetts; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-11-09).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-09 | The Goldman Sachs Group, Inc. | 3.3% |
| Schedule 13G/A, 2026-08-14 | Ridgeback Capital Investments L.P. | 8.7% |
| Schedule 13D/A, 2026-08-11 | Baker Bros. Advisors LP | 11.8% |
| Schedule 13G, 2026-08-10 | The Goldman Sachs Group, Inc. | 5.3% |
| Schedule 13G, 2026-08-07 | State Street Corporation | 5.3% |
| Schedule 13G/A, 2026-08-06 | Montanova Capital, LLC | 7.9% |
| Schedule 13G, 2026-05-21 | Ridgeback Capital Investments L.P. | 7.6% |
| Schedule 13G/A, 2026-05-15 | Rtw Investments, LP | 8.9% |
| Schedule 13G, 2026-05-12 | Suvretta Capital Management, LLC | 5.1% |
| Schedule 13G/A, 2026-05-07 | T. Rowe Price Associates, Inc. | 0.2% |
| Schedule 13G/A, 2026-02-17 | Forbion Capital Fund Iii Cooperatief U.A. | 3.5% |
| Schedule 13G/A, 2025-11-14 | Redmile Group, LLC | 0.7% |
Questions about who owns Replimune Group, Inc.
Who owns Replimune Group, Inc.?
On this page, 6 holders' latest ownership filings report 5% or more of Replimune Group, Inc.: Baker Bros. Advisors LP (11.8%, Schedule 13D/A, filed 2026-08-11), Rtw Investments, LP (8.9%, Schedule 13G/A, filed 2026-05-15), Ridgeback Capital Investments L.P. (8.7%, Schedule 13G/A, filed 2026-08-14), Montanova Capital, LLC (7.9%, Schedule 13G/A, filed 2026-08-06) and State Street Corporation (5.3%, Schedule 13G, filed 2026-08-07); 1 more is listed above.
Who are the largest shareholders of Replimune Group, Inc.?
By the share each holder's latest filing reports, the largest holders of Replimune Group, Inc. on this page are Baker Bros. Advisors LP (11.8%), Rtw Investments, LP (8.9%) and Ridgeback Capital Investments L.P. (8.7%).
When did Baker Bros. Advisors LP buy into Replimune Group, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Baker Bros. Advisors LP on this page is the Schedule 13D/A, filed 2026-08-11, reporting 11.8%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Replimune Group, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Replimune Group, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Replimune Group, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Replimune Group, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Baker Brothers Life Sciences LP, a director and 10% owner: 10,116,095 shares (10.7% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 3, 2025-03-07).
- 667, L.P., a director and 10% owner: 10,116,095 shares (10.7% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 3, 2025-03-07).
- , a director and 10% owner: 10,116,095 shares (10.7% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 3, 2025-03-07).
- Baker Bros. Advisors (GP) LLC, a director and 10% owner: 10,116,095 shares (10.7% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 3, 2025-03-07).
- , a director and 10% owner: 10,116,095 shares (10.7% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 3, 2025-03-07).
Shares outstanding: 94,800,404 as of 2026-10-23, from the company's latest SEC cover page.
How much has Replimune Group, Inc. raised?
No fundraising or offering filing from Replimune Group, Inc. is on file with us.
Keep reading
More on Replimune Group, Inc. and the records around it.
Replimune Group, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
Companies that share a holder
- Ridgeback Capital Investments L.P. also filed stake reports on 3 other companies: Lenz Therapeutics, Inc. (Feb 2026), iTeos Therapeutics, Inc. (Nov 2025), Semler Scientific, Inc. (Nov 2025)
- Redmile Group, LLC also filed stake reports on 18 other companies: FATE THERAPEUTICS INC (Nov 2026), Electra Therapeutics, Inc. (Sep 2026), Neurogene Inc. (Aug 2026)
- Montanova Capital, LLC also filed stake reports on 22 other companies: Veradermics, Inc (Aug 2026), Abeona Therapeutics Inc. (Aug 2026), Fulcrum Therapeutics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/replimune